References

  1. M.J. Roman, R.B. Devereux, J.R. Kizer, E.T. Lee, J.M. Galloway, T. Ali, J.G. Umans, and B.V. Howard, “Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure. The Strong Heart Study,” Hypertension, May. 2007, p. HYPERTENSIONAHA.107.089078.

  2. M.J. Roman, R.B. Devereux, J.R. Kizer, P.M. Okin, E.T. Lee, W. Wang, J.G. Umans, D. Calhoun, and B.V. Howard, “High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome: The Strong Heart Study,” J Am Coll Cardiol, vol. 54, Oct. 2009, pp. 1730-1734.

  3. A. Avolio, “Central Aortic Blood Pressure and Cardiovascular Risk: A Paradigm Shift?,” Hypertension, vol. 51, Jun. 2008, pp. 1470-1471.

  4. P. Boutouyrie, A. Achouba, P. Trunet, S. Laurent, and for the EXPLOR Trialist Group, “Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination: The EXPLOR Study,” Hypertension, vol. 55, Jun. 2010, pp. 1314-1322.

  5. A. Lowe, W. Harrison, E. El-Aklouk, P. Ruygrok, and A.M. Al-Jumaily, “Non-invasive model-based estimation of aortic pulse pressure using suprasystolic brachial pressure waveforms,” Journal of biomechanics, vol. 42, 2009, pp. 2111-2115.

  6. R.A. Payne, I.B. Wilkinson, and D.J. Webb, “Arterial Stiffness and Hypertension: Emerging Concepts,” Hypertension, vol. 55, 2009, pp. 9-14.

  7. I.B. Wilkinson, K. Prasad, I.R. Hall, A. Thomas, H. MacCallum, D.J. Webb, M.P. Frenneaux, and J.R. Cockcroft, "Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia," J Am Coll Cardiol, vol. 39, Mar. 2002, pp. 1005-1011.

  8. M. Shimizu and K. Kario - Review: Role of the augmentation index in hypertension - Therapeutic Advances in Cardiovascular Disease, vol. 2, Feb. 2008, pp. 25-35.

  9. P. Boutouyrie, A. Achouba, P. Trunet, S. Laurent, and for the EXPLOR Trialist Group - Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination: The EXPLOR Study - Hypertension, vol. 55, Jun. 2010, pp. 1314-1322.

  10. B.P. McGrath, Y.L. Liang, D. Kotsopoulos, and J.D. Cameron - Impact of physical and physiological factors on arterial function - Clinical and Experimental Pharmacology & Physiology, vol. 28, Dec. 2001, pp. 1104-1107.

  11. I.B. Wilkinson, H. MacCallum, L. Flint, J.R. Cockcroft, D.E. Newby, and D.J. Webb - The influence of heart rate on augmentation index and central arterial pressure in humans - The Journal of Physiology, vol. 525, May. 2000, pp. 263-270.

  12. I.B. Wilkinson, K. Prasad, I.R. Hall, A. Thomas, H. MacCallum, D.J. Webb, M.P. Frenneaux, and J.R. Cockcroft - Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia - J Am Coll Cardiol, vol. 39, Mar. 2002, pp. 1005-1011.

  13. J. Nürnberger, A. Keflioglu-Scheiber, A.M. Opazo Saez, R.R. Wenzel, T. Philipp, and R.F. Schäfers, - Augmentation index is associated with cardiovascular risk - Journal of Hypertension, vol. 20, Dec. 2002, pp. 2407-2414.

  14. A. Wykretowicz, K. Adamska, P. Guzik, T. Krauze, and H. Wysocki - Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects - Clinical and Experimental Pharmacology & Physiology, vol. 34, Oct. 2007, pp. 1005-1009.